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Abstract 
Cigarette smoking is associated with elevated risk of anxiety and mood disorder. Using the 
7.5% carbon dioxide (CO2) inhalation model of anxiety induction, we examined the effects of 
smoking status and abstinence from smoking on anxiety responses.  
 
Physiological and subjective responses to CO2 and medical air were compared in smokers 
and non-smokers (Experiment One) and in overnight abstinent and non-abstinent smokers 
(Experiment Two).  
 
CO2 induced greater increases in blood pressure in non-smokers compared with smokers (ps 
< 0.043), and greater increases in anxiety (p = 0.005) and negative affect (p = 0.054) in non-
abstinent compared with abstinent smokers.  
 
CO2 increased physiological and subjective indices of anxiety. There were differences across 
smoking groups indicating that the CO2 inhalation model is a useful tool for examining the 
relationship between smoking and anxiety. The findings suggested that both acute smoking 
and acute abstinence may protect against anxious responding. Further investigation is needed 
in long-term heavy smokers. 
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Effects of 7.5% Carbon Dioxide Inhalation on Anxiety and Mood in Cigarette Smokers 
 
Introduction 
 
Cigarette smoking is strongly associated with elevated risk of anxiety and depression, and 
there is growing evidence that the relationship is bidirectional [Paperwalla et al., 2004, 
Munafo et al., 2008, Cosci et al., 2010, Munafo et al., 2010, Lewis et al., 2011]. Smokers 
often report smoking in times of low mood and anxiety, and identify anxiety as a trigger of 
cigarette seeking and relapse. The belief that smoking reduces anxiety is strong among 
smokers, but there is little empirical evidence of anxiolytic effects in non-deprived smokers. 
In contrast, acute withdrawal from smoking increases feelings of anxiety [Hughes, 2007]. 
Therefore, while cigarette smokers report smoking to alleviate anxiety, they may in fact 
simply be smoking to alleviate abstinence-induced anxiety, in particular given the fast action 
and clearance of nicotine.  
 
While the link between cigarette smoking and anxiety is well described, the causal nature of 
the relationship remains unclear. Epidemiological studies that prospectively examine this 
relationship have identified anxiety as a risk factor for smoking initiation, nicotine 
dependence and relapse [Patton et al., 1998, Park et al., 2009, Mckenzie et al., 2010]. The 
proposed mechanisms for this include increased peer influence (particularly in relation to 
initiation of smoking) [Patton et al., 1998] and smoking as anxiolytic self-medication [Park et 
al., 2009]. However, smoking has also been shown to predict the incidence of depression 
[Johnson et al., 2000, Mojtabai et al., 2013, Moylan et al., 2013] generalised anxiety and 
panic disorder [Zvolensky et al., 2005, Moylan et al., 2012].  
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A number of explanations have been offered to account for the elevated risk of anxiety and 
anxiety disorders in smokers, and these vary depending on the specific anxiety disorder 
considered. The relationship between panic and smoking has been attributed to smoking-
induced respiratory abnormalities [Caldirola et al., 2004], which may increase sensitivity to 
respiratory signals that induce or maintain panic symptoms [Klein, 1993]. Zvolensky [2003] 
proposes a pathoplasty model in which smoking modifies panic disorder by inducing acute 
physical changes akin to fearful bodily sensations (such as autonomic effects, noradrenaline 
release). Alongside these changes, the act of smoking also negatively impacts on perception 
of general health and can produce actual medical disturbance that further contribute to panic 
symptomology [Zvolensky et al., 2003]. 
 
There is also general consensus that repeated tobacco exposure can directly alter the stress 
systems of the body [Bruijnzeel, 2012], which may explain more generalised changes in 
anxiety and anxiety sensitivity. Nicotine, the main psychoactive constituent of tobacco, acts 
primarily at the nicotinic acetylcholine receptors (nAChRs), which are widespread 
throughout the brain [Picciotto et al., 2002]. Their activation affects many neurotransmitter 
systems and neural regions involved in the stress response, including the hippocampus which 
is a key output centre regulating hypothalamic-pituitary-adrenal axis (HPA) function 
[Jacobson et al., 1991]. Acutely, cigarette smoking activates the HPA axis and increases 
adrenocorticotropic hormone (ACTH) and cortisol levels [Kirschbaum et al., 1992, Steptoe et 
al., 2006], and repeated smoking results in desensitisation and upregulation of nAChRs [Dani 
et al., 1996] and changes basal activity of the HPA [Rohleder et al., 2006].  
 
These changes provide a biological explanation for the smoking-related vulnerability towards 
anxiety, and the differences in reported anxiety between smokers and non-smokers. Despite 
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smokers reporting anxiolytic effects of smoking [Nichter et al., 1997, Fidler et al., 2009],  
they often show higher levels of anxiety and anxious arousal than non-smokers [Parrott, 
1999, Collins et al., 2009, Ameringer et al., 2010]. Acute smoking abstinence is associated 
with a negative affective comprising low mood, irritability, anxiety and craving [Hughes et 
al., 1986, Perkins et al., 1992, Benowitz, 2008], and smoking relieves these symptoms. 
Therefore, smokers may come to believe that smoking reduces anxiety, when in fact it simply 
alleviates withdrawal-related anxiety [Hughes et al., 1984].  In contrast, long-term abstinence 
from smoking is associated with marked reductions in anxiety [Mcdermott et al., 2013]. 
Understanding the true nature of the smoking-anxiety interaction is important as a 
misperception of anxiolytic effects of smoking and anxiogenic effects of smoking cessation 
may promote smoking maintenance and negate quit attempts. In order to investigate these 
relationships, it is logical to stimulate anxiety in a controlled research setting, and a variety of 
anxiogenic models have been used in laboratory settings. Childs and de Wit [2010] exposed 
non-deprived smokers to a psychosocial stressor (Trier Social Stress Test) and found that 
cigarette craving and pleasure from first cigarette, but not smoking, were increased in 
response to the stressor compared to a non-stressful control task. Increases in actual smoking 
behaviour have been observed in response to other “stressful” manipulations including loud 
noise exposure [Cherek, 1985] and stage performances [Rose et al., 1983]. These findings 
indicate that anxiety-provoking situations incite craving and increased smoking in some 
instances, but subjective anxiety levels were not measured directly, which limits the 
interpretation of these findings. Furthermore, psychological models of anxiety induction are 
often limited in terms of their external validity, practicality and the degree of individual 
variation in responding. 
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To circumvent some of these issues, respiratory challenges that involve breathing air with 
increased levels of carbon dioxide have been used [Zvolensky et al., 2001]. This can be 
achieved in a number of ways, one of which is by individuals rebreathing air in a closed 
system. Using this method Abrams [2008] found decreased respiratory rate but increased 
report of panic symptoms in a group of nicotine withdrawn heavy smokers compared with 
non-smokers. In a follow up study comparing abstinent and non-abstinent smokers, Abrams 
[2011] did not find an effect of smoking status on response to a 5-minute rebreathing 
procedure, although pre-challenge withdrawal symptoms were associated with stronger 
subjective responses to the challenge. A limitation of this technique is that the level of CO2 
inhaled gradually increases over time and therefore inhalation techniques that deliver fixed 
levels of CO2-enriched air afford the researcher greater control of the anxiety response. 
 
Another respiratory challenge involves controlled inhalation of air mixtures that have higher 
CO2 concentrations than normal air. Like other CO2 challenges, these inhalations induce 
physiological and psychological symptoms of anxious arousal. The effects of CO2 appear to 
be dose dependent with higher doses producing panic-like symptoms and lower doses 
producing less intense generalised anxiety [Bailey et al., 2007]. In support, single breath of 
35% CO2 concentration, but not lower doses, reliably stimulates ACTH and cortisol release 
[Kaye et al., 2004]. However, some individuals experience panic attacks and panic-like 
symptoms at lower doses [Zvolensky et al., 2001]. Due to the high prevalence of smoking 
among panic disorder patients [Mccabe et al., 2004], several studies have examined the 
effects of higher CO2 concentrations (around 20% – 35%). Cosci et al. [2006] investigated the 
effect of transdermal nicotine (via skin patch) on reactivity to 35% CO2 challenge in non-
smokers. Although nicotine patch increased baseline autonomic activation compared to 
placebo patch, there was no effect of patch type on CO2 reactivity. Using 20% challenge, 
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Zvolensky et al. [2001] were able to differentiate between smokers who able and unable to 
maintain quit attempts for seven days, with evidence of increase reactivity in those who 
reported being unable do so. The effects of lower CO2 concentration (i.e., 5% – 10%) have 
been largely unexplored in smoking research. The effects of withdrawal on stress reactivity 
have been explored using 10% CO2 challenge and these studies have shown that higher levels 
of withdrawal are associated with greater stress reactivity in individuals with panic disorder 
[Leyro et al., 2013] and high anxiety sensitivity [Vujanovic et al., 2009]. 
 
The current study extends previous research by exploring the relationship between smoking 
and anxiety using a lower 7.5% CO2 concentration. The effects of this dose in healthy 
volunteers are now well described [Bailey et al., 2005]; compared with the inhalation of air, 
this produces marked increases in heart rate and blood pressure, and corresponding increases 
in subjective ratings of anxiety, fear and tension, with decreased subjective ratings of feeling 
relaxed and happy. These effects are sustained throughout the 20 minute inhalation, with 
rapid recovery when inhalation of normal air is resumed. A single dose of the 
benzodiazepines lorazepam, alprazolam and zolpidem reduces the subjective effects of 7.5% 
CO2 [Bailey et al., 2007, Bailey et al., 2009], as does 3-week treatment with the serotonin 
reuptake inhibitor paroxetine [Bailey et al., 2007]. Furthermore, this challenge induces 
cognitive biases characteristic of anxiety [Garner et al., 2011, Cooper et al., 2012].  
 
 Based on previous findings, we hypothesised that smokers would show greater stress 
reactivity than non-smokers (Experiment One) and abstinent smokers would show greater 
anxiogenic response and higher craving compared to non-abstinent smokers (Experiment 
Two). These studies also informed the validity of the 7.5% CO2 model as a tool for future 
smoking research.  
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Experiment One 
 
Methods 
 
Design and overview: The experiment consisted of a repeated-measures design, with gas (air, 
7.5% CO2) as the within-subjects factor and smoking status (smoker, non-smoker) as a 
between-subjects factor. The order of gas inhalation was counterbalanced across participants. 
 
Participants: Twelve smokers (smoke at least 5 cigarettes per day and within one hour of 
waking) and twelve non-smokers (current non-smokers and have smoked no more than 100 
cigarettes in lifetime) were recruited from the staff and students of the University of Bristol 
and from a participant database. Exclusion criteria were current or a history of psychiatric 
disorder or drug or alcohol dependence (excluding caffeine), assessed using a structured 
interview by a trained researcher, based on the Mini-International Neuropsychiatric Interview  
(MINI; Sheehan et al., 1998). Blood pressure (<140/90 mmHg), heart rate (50–90 bpm) and 
body mass index (BMI; 18–30 kg/m2) were required to be within the normal range. Prior to 
the study, participants were asked to refrain from alcohol for 36 hours, and from caffeine 
after midnight. Participants were reimbursed £20 for their time at the end of testing. The 
study was reviewed and approved by the University of Bristol Faculty of Science Research 
Ethics Committee. 
 
Gas mixtures: The gas mixtures used were CO2 7.5%/O2 21%/N 71.5% and medical air (O2 
21%; BOC Ltd.). These were administered to participants using a oro-nasal mask (Hans 
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Rudolph, Kansas City, MO, USA), which was attached to a 500 L bag with tubing. For safety 
reasons, the gas was administered single-blind. 
 
Physiological assessment: Participants were tested for alcohol and carbon monoxide levels in 
exhaled breath using the Alcohawk PT400 (Q3 Innovations, Independence, IA, USA) and the 
Bedfont Micro Smokerlyser (Bedfont Scientific Ltd, Maidstone, UK), respectively. Blood 
pressure was recorded using the OMRON M6 Comfort Digital Blood Pressure Monitor 
(OMRON Healthcare Ltd, Milton Keynes, UK). Fresh urine samples were provided to test for 
the presence of barbiturates, benzodiazepines, opiates, tetrahydrocannabinol (THC), 
methamphetamine, amphetamine and cocaine, and to test for pregnancy in female 
participants (Surescreen Diagnostics Ltd, Derby, UK). 
 
Psychological assessment: Participants completed the Spielberger State-Trait Anxiety 
Inventory State (STAI-S) and Trait (STAI-T) subscales (Spielberger, 1983), Anxiety 
Sensitivity Inventory (ASI) [Reiss et al., 1986], and the Positive and Negative Affect 
Schedule positive (PANAS-P) and negative (PANAS-N) subscales [Watson et al., 1988]. 
Cigarette craving was measures using the Questionnaire on Smoking Urges (QSU) [Tiffany 
et al., 1991]. 
 
Procedure: Participants completed an initial telephone screening before attending the testing 
session, in order to ascertain likely eligibility for the study. Smokers were required to be 
abstinent from smoking overnight (i.e., at least 12 hours), but were asked to smoke one of 
their own cigarettes before entering the laboratory in order to keep recent smoking levels 
consistent within the smoker group. On the day of testing, participants provided signed 
informed consent, and then completed further screening procedures, including exhaled breath 
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and urine testing, assessment of blood pressure, heart rate, height and weight, and completion 
of the psychiatric screening interview. Eligible participants then completed the STAI-S, 
STAI-T, ASI, PANAS-P, and PANAS-N measures prior to the first inhalation. Inhalations of 
air and CO2 each lasted for twenty minutes. Inhalations periods were separated by 40 minutes 
of rest, and the order of air and CO2 was counterbalanced across participants. Throughout the 
study, an experimenter remained within close proximity of the gas cylinders to ensure the bag 
was adequately full at all times. Participants sat with their back to the gas cylinders. 
Immediately after each inhalation, blood pressure and heart rate were recorded while the 
participant remained seated, and the STAI-S, PANAS and QSU (smokers only) were then 
completed. While anxiety induced by the inhalation is sustained during inhalation, it declines 
very rapidly on inhalation of normal air. Participants were therefore asked to indicate how 
they felt during the inhalation when the effects of the gas were “at their strongest” when 
completing the questionnaire measures at the end of the inhalation. Participants were then 
required to stay in the laboratory with the researcher for a further 30 minutes (post end of last 
inhalation) to allow for recovery (as assessed through heart rate and blood pressure response 
and participant self-report).  
 
Statistical analysis: Data were analysed by repeated measures ANOVA, with gas (air, CO2) 
as a within-subjects factor, and smoking status (smoker, non-smoker) as a between-subjects 
factor.  For effects of gas on craving, t-tests were run on craving scores after CO2 and air in 
smoking group only. To explore the relationship between subjective anxiety and craving 
Pearson’s correlations were conducted on post-CO2 SSAI and QSU scores. All analyses were 
performed using PASW Statistics version 18 (SPSS Inc., Chicago IL, USA). Precise p-values 
are reported throughout. 
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Previous research has indicated that inhalation of 7.5% CO2 increases state anxiety by 
approximately 19 points (SD 8.5 points) compared to inhalation of air. Our sample size 
therefore provided 99% power to detect an effect of inhalation of 7.5% CO2 versus inhalation 
of air on subjective anxiety, and 80% power to detect a difference of 10 points between 
smokers and non-smokers in the increase in anxiety induced by inhalation of 7.5% CO2, 
assuming an alpha level of 5%. This effect is comparable to that observed for the effects of 
anxiolytic medications on response to inhalation of 7.5% CO2 (Bailey et al., 2007). 
 
Results 
 
Characteristics of participants: Participant characteristics (n = 24; 50% female) at baseline 
are shown in Table 1, and did not differ between smokers and non-smokers (ps > 0.48).  
 
 Insert Table 1 about here. 
 
Cardiovascular measures: CO2 inhalation increased systolic blood pressure (F [1, 22] = 
28.48, p < 0.001, η2 = 0.56), diastolic blood pressure (F [1, 22] = 4.89, p = 0.038, η2 = 0.18), 
and heart rate (F [1, 22] = 13.31, p = 0.001, η2 = 0.38) compared with air inhalation (Table 
2). For systolic and diastolic blood pressure, the gas × smoking status interaction terms 
indicated that these effects were stronger in non-smokers than smokers (ps < 0.043). This was 
not observed for heart rate (p = 0.89). 
 
Anxiety and mood: CO2 inhalation increased state anxiety (F [1, 22] = 18.72, p < 0.001, η2 = 
0.46) and negative affect (F [1, 22] = 11.98, p = 0.002, η2 = 0.35), compared with air 
inhalation (Table 2). There was no main effect on positive affect (p = 0.12), and the gas × 
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smoking status interaction terms indicated that there was no evidence that these effects 
differed by smoking status (ps > 0.10). These results are shown in Figure 1 (panel a). 
 
Insert Figure 1 about here. 
 
Cigarette craving: There was no difference in craving among smokers after CO2 (M = 32.9, 
SD = 12.0) compared to air (M = 30.3, SD = 9.8) (t = .91, df = 11, p = .38). Post-CO2 craving 
did not correlate with post-CO2 anxiety (p = .67). 
   
Discussion 
CO2 inhalation consistently increased cardiovascular parameters and self-reported anxiety 
and negative affect compared with air. Smokers showed reduced physiological responses to 
CO2 inhalation than non-smokers, with lesser increases in blood pressure. There was no 
interaction between gas and smoking status for self-reported anxiety and negative affect. The 
lesser physiological response in the smokers may be due to an anxiolytic effect of smoking, 
which may be a conditioned response (i.e., learned association between smoking and 
anxiolysis that may be withdrawal related) or due to a pharmacological anxiolytic effect of 
nicotine. The smokers in this study smoked before entering the laboratory. While these 
findings suggest no exacerbated anxiety responses to this challenge in non-abstinent smokers, 
it remains unclear how abstinence may explain these responses. In regular smokers, 
abstinence from smoking results in a range of physiological and subjective symptoms, 
including increased anxiety, and previous research has reported increased panic symptoms in 
withdrawn smokers following a rebreathing procedure [Abrams et al., 2008]. Furthermore, it 
is widely accepted that anxiety is a risk factor for smoking and smoking relapse [Parrott, 
1998, Albertsen et al., 2006]. Therefore, smokers may be particularly vulnerable to anxiety 
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when in a withdrawn state, and this was investigated in Experiment Two, which compared 
reactivity to the CO2 challenge in a group of abstinent and non-abstinent daily smokers. 
 
Experiment Two 
 
Methods 
 
Design and overview: The experimental design and study procedures were identical to those 
described in Experiment One, with the exception that only smokers were recruited. 
Participants were randomised to abstain from smoking for 12 hours prior to testing, or smoke 
as usual (with their last cigarette being smoked just prior to entering the laboratory). A 
balanced randomisation schedule (i.e., equal numbers per group) was produced using random 
number generation software. Gas order was not counterbalanced (the air inhalation was 
administered first). Participants were told that they would complete two inhalations, one of 
(normal) air and one of CO2–enriched air, but they were not told the order in which they 
would receive these mixtures. The fixed order schedule was utilised due to increases in 
anxiety during the first inhalation (regardless of gas content), which may have inflated the 
anxiolytic effect of the gas by interacting with the CO2-induced anxiety. To create a more 
conservative test, medical air was administered first throughout. 
 
Participants: Twenty-four smokers (smoke at least 5 cigarettes per day and within one hour 
of waking) were recruited from the staff and students of the University of Bristol and from a 
participant database, and randomised to either abstinent or non-abstinent conditions (twelve 
participants per group). All inclusion and exclusion criteria were identical to those described 
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in Experiment One. None of the participants recruited had taken part in Experiment One. 
Abstinence status on the day of testing was confirmed by exhaled CO monitoring (< 7 ppm).  
 
Statistical analysis: Data were analysed by repeated measures ANOVA, with gas (air, CO2) 
as a within-subjects factor, and smoking abstinence (abstinent, non-abstinent) as a between-
subjects factor. Analyses were performed with and without adjustment for changes in craving 
between gas conditions. To explore the relationship between subjective anxiety and craving 
Pearson’s correlations were conducted on post-CO2 SSAI and QSU scores. All analyses were 
performed using PASW Statistics version 18 (SPSS Inc., Chicago IL, USA). Precise p-values 
are reported throughout.  
 
Results 
  
Characteristics of participants: Participant characteristics (n = 24; 46% female) at baseline 
are shown in Table 1. There were baseline differences in craving (t = 4.31, df = 22, p <0.001) 
and heart rate (t = 2.81, df = 22, p = 0.010) with higher craving (M = 42.9, SD = 12.8 versus 
M = 22.3, SD = 10.5) and lower heart rate (M = 68.6, SD = 9.8 versus M = 79.8, SD = 9.8) in 
abstinent versus non-abstinent smokers. There were no other differences between abstinence 
groups (ps > 0.10). 
 
Cardiovascular measures: CO2 inhalation increased systolic blood pressure (F [1, 22] = 4.89, 
p = 0.038, η2 = 0.18), compared with air inhalation (Table 2). There were no main effects on 
diastolic blood pressure (p = 0.13) or heart rate (p = 0.65), and the gas × abstinence 
interaction terms indicated that there was no evidence that these effects differed by 
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abstinence status (ps > 0.36). These results were not altered when change in craving was 
included as a covariate. 
 
Anxiety and mood: CO2 inhalation increased state anxiety as measured by SSAI (F [1, 22] = 
52.13, p < 0.001, η2 = 0.70) and negative affect (F [1, 22] = 21.76, p < 0.001, η2 = 0.50), and 
decreased positive affect (F [1, 22] = 5.24, p = 0.032, η2 = 0.19) compared with air inhalation 
(Table 2). For state anxiety, the gas × abstinence interaction term indicated that this effect 
was stronger in non-abstinent smokers than abstinent smokers (p = 0.005). A similar pattern 
was observed more weakly for negative affect (p = 0.054), but not positive affect (p = 0.27). 
These results are shown in Figure 1 (panel b), and were not altered when change in craving 
was included as a covariate. 
 
Craving: There was no effect of gas on craving (p = .82), but craving was higher in the 
abstinent group (M = 40.4, SD = 12.5) than non-abstinent group (M = 29.5, SD = 13.1) (F [1, 
22] = 4.37, p = 0.048, η2 = 0.17). There was a gas × abstinence interaction (F [1, 22] = 5.67, p 
= 0.026, η2 = 0.21), with non-abstinent smokers showing higher craving after CO2 compared 
to air (t = 2.24, df = 11, p = 0.046), but no difference between CO2 and air in abstinent 
smokers (p = 0.21) (Figure 1, panel b). Post-CO2 craving did not correlate with post-CO2 
anxiety across the collective data set (p = .998), but based on the gas × abstinence interaction 
correlations were conducted separately for each abstinent group. There was evidence of a 
correlation in the non-abstinent group (r = .53, n = 12, p = 0.075) but not the abstinent group 
(r = -.35, n = 12, p = 0.26). 
 
Discussion 
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CO2 inhalation increased subjective anxiety and systolic blood pressure, and induced negative 
changes in mood. Overnight abstinent smokers showed lesser response to CO2 than did non-
abstinent smokers. Furthermore, abstinent smokers did not show increases in craving after 
CO2 compared to air as was observed in non-abstinent smokers. These findings suggest that 
abstinence from smoking may have beneficial effects on anxious responding in smokers 
[Parrott, 1995, West et al., 1997]. The relationship between smoking and anxiety is 
undoubtedly complex. Paradoxically, smokers often assert that smoking is anxiolytic, yet at a 
population level, smokers report higher levels of anxiety than do non-smokers [Parrott, 
1998]. Anxiolytic effects reported by smokers may actually be due to reversal of an 
anxiogenic smoking withdrawal state that develops with chronic smoking, and as a result 
smokers may come to associate the act of smoking with reductions in anxiety and smoke in 
times of stress. Although our findings did not indicate heightened reactivity to CO2 in 
abstinent smokers, it is noteworthy that this group did not differ from the non-abstinent group 
on state measures of anxiety or positive or negative affect, as would be expected in 
individuals experiencing acute nicotine withdrawal. This lack of withdrawal symptoms 
suggests that our sample were not strongly tobacco dependent. We recruited individuals who 
smoked at least five cigarettes per day and who smoked within one hour of waking in the 
morning (which are considered reliable indicators or smoking dependence). There were group 
differences in baseline levels of craving with higher craving in abstinent smokers as would be 
expected for smokers who usually smoke upon waking, but as noted above this craving 
difference was independent of other withdrawal symptoms such as negative affect. We did 
not record the number of years smoked. Given the young age of many of our participants, it is 
unlikely that many have sustained the regular pattern of smoking for very long, and therefore 
may not have experienced the physiological changes associated with long-term regular 
smoking. These data indicate a dissociation between craving and negative affect in our 
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sample of abstinent smokers. Future research should replicate this study in a sample of 
heavier smokers with a longer smoking history, who would be expected to show withdrawal 
syndrome upon acute abstinence from smoking.  
 
General Discussion 
 
Inhalation of CO2-enriched air increased physiological and subjective indices of anxiety and 
negative affect in both experiments, providing validation of its use as a model of anxiety 
induction in experimental studies. Furthermore, gas by smoking group interactions were 
observed in both experiments, indicating that responses to the gas are influenced by smoking-
related variables. Lower reactivity to CO2 was observed in smokers compared with non-
smokers (Experiment One) and in abstinent compared with non-abstinent smokers 
(Experiment Two). 
 
These findings suggest that during periods of smoking, smokers do not show substantial 
increases in anxious responding, as demonstrated by lesser reactivity to CO2 than non-
smokers (Experiment One). Despite this, there was also evidence that acute abstinence from 
smoking may be beneficial, reducing anxious responding beyond that of non-abstinent 
smokers (Experiment Two). It is important to note that there was little evidence of negative 
withdrawal symptoms in our overnight abstinent sample, and therefore these findings may 
only generalise to abstinence in the absence of marked withdrawal symptoms. 
 
Interactions between gas and smoking group were observed in both experiments, yet the 
dependent variable for which the interaction was obtained differed across studies. These were 
systolic and diastolic blood pressure in Experiment One and state anxiety and negative affect 
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in Experiment Two. While it is possible that different smoking variables have differential 
effects across anxiety parameters, it seems that there were more general patterns of reactivity 
change that simply did not reach statistical significance on all dependent measures. For 
example, in Experiment One, in addition to reduced blood pressure response to the gas, 
smokers also showed a pattern consistent with reduced subjective anxiety and negative (see 
Figures 1 and two, panels A). However, the smoking groups in Experiments One and Two 
differed in relation to gas-related craving. The non-abstinent group in Experiment Two 
reported higher craving after CO2 compared to air but this effect was not observed in 
Experiment One (where the smokers had the same abstinence profile). This suggests possible 
differences in the smokers between the two studies, despite use of the same inclusion criteria. 
This variation again may be partly due to the inclusion of some smokers with short smoking 
histories and low dependence. Both groups reported increases in anxiety after CO2 suggesting 
a partial dissociation between anxiety and craving. 
 
Taken together, these findings support an acute anxiolytic effect of smoking as has been 
reported elsewhere [Jarvik et al., 1989, Cohen et al., 2009]. However, it has been suggested 
that this effect is relatively short-lived [Szyndler et al., 2001], and that chronic smoking 
induces physiological changes [Rohleder et al., 2006] that may increase basal levels anxiety 
in smokers compared to non-smokers [Sheahan et al., 2006]. The absence of withdrawal 
symptoms (i.e., negative affect) in the abstinent group suggests low levels of dependency. 
Instead of the expected higher reactivity to the gas in abstinent smokers, we observed lower 
anxiety and craving in this group. These findings imply that abstinence may be beneficial 
when not accompanied by a pronounced withdrawal syndrome which supports the contention 
that long term abstinence (i.e., post-withdrawal) from smoking has beneficial effects on 
anxiety and anxious responding [Mcdermott et al., 2013]. However, Leyro et al. [2013] 
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investigated panic responses to 10% CO2 challenge in heavier smokers, and found that high 
nicotine withdrawal was only associated with greater panic attack symptoms in individuals 
with panic disorder. In contrast, healthy controls had lower symptomology when heavily 
withdrawn from smoking, suggesting that the withdrawal may not be strongly associated with 
stress reactivity. However, this study examined more extreme (panic-related) outcomes and 
future research should examine withdrawal effects in heavy long-term smokers on subjective 
anxiety.   
 
The relationship between smoking and anxiety is complex and may vary depending on the 
smoking variable under investigation [Leventhal et al., 2013] and also as a function of 
individual differences. There are also reports of gender differences with females showing 
greater increases in negative affect (including anxiety) during smoking abstinence [Pang et 
al., 2013]. In a qualitative review of the smoking-affect literature, Ameringer and Leventhal 
[2010] identified associations with negative affect and emotional arousal with smoking status  
but not smoking heaviness. The current studies assessed changes in phasic craving as a 
function of anxiety-induction but future research should consider a wider range of smoking 
variables and individual differences. Furthermore, due to the nature of the manipulation and 
sample, it is difficult to directly extrapolate from the effect sizes we observed to clinical 
significance. However, the study was powered to detect effects comparable in magnitude to 
studies of the effects of anxiolytic medications on response to inhalation of 7.5% CO2 [Bailey 
et al., 2007]. 
 
There are some limitations of the current studies which should be acknowledged. First, the 
sample was predominately students from the University of Bristol. This may limit the 
generalisability of findings to the wider population. Second, while the studies were 
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sufficiently powered to demonstrate effects of the CO2 inhalation on anxious outcomes, the 
small sample size may underlie the relatively weak statistical evidence for the key interaction 
effects. Therefore, these findings should be replicated using a larger sample. Third, a number 
of personal and situational variables may affect smoking and anxiety outcomes, including 
fitness, sleep levels and menstrual cycle, which were not controlled for in the current studies.  
 
These experiments are the first to use the 7.5% CO2 anxiety induction model to investigate 
the relationship between smoking and anxiety. The model consistently increased 
physiological and subjective indices of anxiety across all experiments. Furthermore, we 
observed differences between smoking groups in anxious responding in both experiments, 
thereby validating the use of this model as a tool to be used in future smoking research. Given 
the important role that anxiety is believed to play particularly in the maintenance and relapse 
to smoking, developing novel and valid tools is an important advancement in the field. As 
well as investigating the effects of smoking variables, such as smoking status and abstinence, 
future research should strive to further elucidate the mechanisms underlying the smoking-
anxiety relationship. Habitual smoking induces changes in a number of biological systems; 
however, other cognitive and psychological factors, including emotional dysregulation, 
outcome expectancies and smoking motives all warrant future investigation. The relationship 
between smoking and anxiety in undoubtedly complex, and while further research is required, 
these studies provide an important first step in the use of physiological anxiety manipulation 
techniques to understand smoking behaviour. 
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Figure 1. Effects of CO2 vs. air on anxiety (SSAI), positive and negative affect (PANAS) and 
craving (QSU) (Experiment Two only) in smokers vs. non-smokers (Experiment One) and 
abstinent vs. non-abstinent smokers (Experiment Two) 
 
Figure 2. Effects of CO2 vs. air on systolic blood pressure, diastolic blood pressure and heart 
rate in smokers vs. non-smokers (Experiment One) and abstinent vs. non-abstinent smokers 
(Experiment Two) 
 
 
